Disruption of the mouse Shmt2 gene confers embryonic anaemia via foetal liver-specific metabolomic disorders by Tani, Haruna et al.
1Scientific RepoRtS |         (2019) 9:16054  | https://doi.org/10.1038/s41598-019-52372-6
www.nature.com/scientificreports
Disruption of the mouse Shmt2 
gene confers embryonic anaemia 
via foetal liver-specific metabolomic 
disorders
Haruna tani1,2,8, Takayuki Mito3,8, Vidya Velagapudi4, Kaori Ishikawa  1,5, Moe Umehara1, 
Kazuto Nakada1,5, Anu Suomalainen3,6 & Jun-ichi Hayashi7*
In a previous study, we proposed that age-related mitochondrial respiration defects observed in elderly 
subjects are partially due to age-associated downregulation of nuclear-encoded genes, including serine 
hydroxymethyltransferase 2 (SHMT2), which is involved in mitochondrial one-carbon (1C) metabolism. 
this assertion is supported by evidence that the disruption of mouse Shmt2 induces mitochondrial 
respiration defects in mouse embryonic fibroblasts generated from Shmt2-knockout E13.5 embryos 
experiencing anaemia and lethality. Here, we elucidated the potential mechanisms by which the 
disruption of this gene induces mitochondrial respiration defects and embryonic anaemia using Shmt2-
knockout E13.5 embryos. The livers but not the brains of Shmt2-knockout E13.5 embryos presented 
mitochondrial respiration defects and growth retardation. Metabolomic profiling revealed that Shmt2 
deficiency induced foetal liver-specific downregulation of 1C-metabolic pathways that create taurine 
and nucleotides required for mitochondrial respiratory function and cell division, respectively, resulting 
in the manifestation of mitochondrial respiration defects and growth retardation. Given that foetal 
livers function to produce erythroblasts in mouse embryos, growth retardation in foetal livers directly 
induced depletion of erythroblasts. By contrast, mitochondrial respiration defects in foetal livers also 
induced depletion of erythroblasts as a consequence of the inhibition of erythroblast differentiation, 
resulting in the manifestation of anaemia in Shmt2-knockout E13.5 embryos.
Human aging and age-related mitochondrial respiration defects are thought to be caused by the age-associated 
accumulation of somatic mutations in mitochondrial DNA (mtDNA)1–7. In contrast to this postulate, our previous 
studies8,9 proposed a different concept of human aging: age-related mitochondrial respiration defects observed in 
the fibroblasts of elderly subjects10 are not due to the accumulation of somatic mutations in mtDNA but to epige-
netic downregulation of nuclear-encoded genes, including serine hydroxymethyltransferase 2 (SHMT2), involved 
in mitochondrial one-carbon (1C) metabolism11. Indeed, remodelled 1C metabolism was recently linked to mito-
chondrial respiration defects and mitochondrial diseases12,13.
The concept that mitochondrial respiration defects in elderly subjects are due partly to epigenetic downregula-
tion of nuclear-encoded SHMT28 is supported by our subsequent findings that knockout of mouse Shmt2 induces 
mitochondrial respiration defects in mouse embryonic fibroblasts (MEFs) obtained from Shmt2-knockout 
embryos and confers embryonic lethality with anaemia14. Moreover, recent reports15–17 revealed that knockout 
of human SHMT2 in cultivated human cell lines induces respiration defects as a result of deprivation of the 
products of mitochondrial 1C metabolism, including taurinomethyluridine bases15 and formylmethionyl-tRNA 
(f-Met tRNA)16, required to translate mtDNA-encoded subunits of mitochondrial respiratory chain complexes. 
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Therefore, the occurrence of age-related mitochondrial respiration defects in elderly subjects might be partially 
explained by the age-associated downregulation of SHMT28 and the resulting downregulation of mitochondrial 
1C metabolism.
The knockout of other genes involved in mitochondrial 1C metabolism sometimes induces embryonic lethal-
ity in mice with either anaemia18 or neural tube defects (NTDs)19–22, indicating induction of tissue-specific onset 
of the disorders in mouse embryos by the disruption of these genes. In the case of Shmt2-knockout embryos, 
macroscopic abnormalities include anaemia and small embryonic sizes14. Given that foetal livers function as 
sites for erythropoiesis (differentiation of erythroblasts) in mouse embryos23, the presence of respiration defects 
in the foetal livers of Shmt2-knockout embryos would be related to the manifestation of anaemia. Moreover, 
considering that not only mitochondrial respiration defects but also growth retardation are commonly observed 
in Shmt2-knockout MEFs14 and in SHMT2-knockout human cell lines15–17, growth retardation alongside mito-
chondrial respiration defects in the foetal livers of Shmt2-knockout embryos would also be involved in the man-
ifestation of anaemia.
Here, we studied the livers and brains of Shmt2-knockout E13.5 embryos to identify the potential mechanisms 
by which Shmt2 disruption induces mitochondrial respiration defects and growth retardation preferentially in 
foetal livers and confers anaemia in Shmt2-knockout E13.5 embryos.
Results
Respiration defects and growth retardation in Shmt2-knockout foetal livers. We previously 
identified that MEFs obtained from Shmt2-knockout E13.5 mouse embryos present mitochondrial respiration 
defects14. Moreover, they manifest significant growth retardation in comparison to MEFs obtained from wildtype 
E13.5 embryos14. In this study, we examined whether foetal tissues—specifically, livers and brains from Shmt2-
knockout E13.5 embryos—also exhibit these abnormalities.
Western blot analysis of livers from Shmt2-knockout E13.5 embryos (Figs 1a and S1) showed decreased levels 
of not only an mtDNA-encoded subunit (MT-CO1) but also some nuclear DNA-encoded subunits (NDUFS4 
and NDUFA9) comprising mitochondrial respiratory chain complexes. By contrast, foetal brains did not show 
these abnormalities (Fig. 1a). Moreover, in-gel activity assays showed preferential reduction in the activity of 
mitochondrial respiratory chain complex I in Shmt2-knockout livers but not in brains (Fig. 1b). Additionally, blue 
native gel analysis showed preferential reductions in the amounts of mitochondrial respiratory chain complexes I, 
III, IV, and V in Shmt2-knockout livers but not in brains (Fig. 1b). These observations suggest that mitochondrial 
respiration defects are induced in the livers but not the brains of Shmt2-knockout E13.5 embryos.
Next, to examine whether foetal tissues without functional Shmt2 exhibit growth retardation, we compared 
the weights of wild-type and Shmt2-knockout E13.5 whole embryos and their tissues. Although a decrease in 
weight was commonly observed in Shmt2-knockout whole embryos and their tissues, a significant decrease in the 
ratio of tissue weight per body weight was observed in foetal livers but not in foetal brains (Fig. 2a). Heterozygous 
Shmt2 m/+ embryos did not show decreases in the weights of tissues and whole embryos (Fig. S2), suggesting the 
absence of a gene-dose effect.
The induction of growth retardation in Shmt2-knockout foetal livers was supported by comparison of the total 
numbers of cells between wild-type and Shmt2-knockout foetal livers, because the results showed their significant 
decrease in Shmt2-knockout foetal livers (Fig. 2b). Therefore, Shmt2 knockout possibly induces both mitochon-
drial respiration defects and growth retardation preferentially in foetal livers.
Given that the foetal liver is the primary site for erythropoiesis during embryogenesis23, growth retardation 
of erythroblasts in foetal livers might result in the induction of anaemia. A question that then arises is whether 
mitochondrial respiration defects in foetal livers might also be responsible for the induction of anaemia.
Arrest of erythroblast differentiation in Shmt2-knockout foetal livers. Our previous study24 and 
others25 show that mitochondrial respiration defects caused by mtDNA mutations in adult bone marrow induce 
anaemia as a consequence of the impaired differentiation of erythroblasts. Therefore, we examined the possibility 
that mitochondrial respiration defects caused by Shmt2 disruption also induce impaired differentiation of eryth-
roblasts in foetal livers by flow cytometric analysis. We used phycoerythrin (PE)-conjugated and allophycocyanin 
(APC)-conjugated antibodies against two cell-surface markers of erythrocyte differentiation [Ter119 antigen and 
a transferrin receptor (CD71), respectively]. CD71 is expressed in erythroblasts during early differentiation and 
its expression is reduced with erythroblast maturation26. Ter119 antigen is expressed during terminal differentia-
tion27. The cells were stained with propidium iodide (PI) to identify and exclude dead cells (Fig. 3a), and the same 
number (3 × 104) of viable cells prepared from wild-type and Shmt2-knockout foetal livers were collected and 
analysed using CD71/Ter119 flow cytometric assays (Fig. 3b,c).
We quantified three populations of foetal liver cells, CD71high/Ter119middle (EI), CD71high/Ter119high (EII), 
and CD71middle/Ter119high (EIII), which mainly correspond to pro-erythroblasts, erythroblasts, and reticulo-
cytes, respectively. The results indicated that the differentiation of pro-erythroblasts to erythroblasts was sig-
nificantly impaired in Shmt2-knockout foetal livers (Fig. 3b,c). Foetal livers did not include populations of 
CD71low/Ter119high (EIV; matured erythrocytes), regardless of whether they were derived from wild-type or 
Shmt2-knockout embryos. Moreover, we observed a significant increase in the population of cells not belonging 
to stages EI through EIV in Shmt2-knockout foetal livers (Fig. 3b), partly reflecting the impaired differentiation 
of erythroid progenitors to pro-erythroblasts.
We were unable to estimate mitochondrial respiratory protein levels in each stage of erythropoiesis due to 
extremely low numbers of cells in stages EI, EIII, and EIV (Fig. 3b). However, the results in Fig. 1 reflect develop-
ing erythroblasts, because >85% of viable cells in E13.5 foetal livers represent developing erythroblasts belonging 
to stages EI through EIV (Fig. 3b). Given that mitochondrial respiration defects induce impaired differentiation 
of erythroblasts in adult bone marrow24,25, it is also possible that they could induce impaired differentiation of 
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erythroblasts in Shmt2-knockout foetal livers (Fig. 3). Therefore, not only growth retardation (Fig. 2) but also 
mitochondrial respiration defects and the resulting arrest of erythroblast differentiation (Fig. 3) induced erythro-
blast depletion in foetal livers and were responsible for the manifestation of anaemia in Shmt2-knockout embryos.
Subsequent questions include how the disruption of Shmt2 induces mitochondrial respiration defects and 
growth retardation and why these abnormalities occur preferentially in the livers but not the brains, even though 
both tissues are derived from Shmt2-knockout E13.5 embryos.
Metabolomic disorders underlying anaemia in Shmt2-knockout embryos. To answer these ques-
tions, we compared metabolomic profiles between the foetal livers of wild-type and Shmt2-knockout embryos 
and between the foetal brains of wild-type and Shmt2-knockout embryos and examined the tissue-specific effects 
of Shmt2 disruption on metabolomic profiles via targeted metabolomics using quantitative mass spectrometry 
(Figs 4 and 5). Because >85% of viable cells in E13.5 foetal livers corresponded to developing erythroblasts 
(Fig. 3b), the metabolic profile of E13.5 foetal livers should reflect mostly the metabolic status of developing 
erythroblasts but not hepatic cells.
Principal component analysis (PCA) (Fig. 4a) showed clear separation of the global metabolomes of wild-type 
and Shmt2-knockout foetal livers, whereas those of wild-type and Shmt2-knockout foetal brains overlapped with 
one another. Moreover, Shmt2 disruption significantly affected 50 metabolites (Fig. 4b) and 42 metabolic path-
ways (Fig. 4c) in foetal livers, whereas only five metabolites (Fig. 4b) and one pathway (Fig. 4c) were affected in 
foetal brains. These observations suggest that Shmt2 is involved in substantially more pathways in foetal livers 
than in foetal brains. Furthermore, pathway analysis (Fig. 4c) showed that Shmt2 disruption in foetal livers sig-
nificantly affected various metabolic pathways involved in 1C metabolism, such as glycine, serine, and threonine 
metabolism, taurine metabolism, and nucleotide metabolism (purine and pyrimidine metabolism).
Of the pathways involved in 1C metabolism affected by Shmt2 disruption in foetal livers, glycine, serine, 
and threonine metabolism (Fig. 4c) can be explained by the fact that SHMT2 catalyses the conversion of serine 
Figure 1. Effects of Shmt2 knockout on mitochondrial respiratory chain complexes of livers and brains from 
E13.5 embryos. (a) Western blot analysis to estimate the quantity of the subunits comprising the mitochondrial 
respiratory chain complexes for comparison between wild-type and Shmt2-knockout foetal tissues. SHMT2, 
SHMT2 protein encoded by Shmt2; NDUSF4 and NDUFA9, nuclear DNA-encoded subunits of respiratory 
chain complex I; MT-CO1, an mtDNA-encoded subunit of respiratory chain complex IV; SDHA, a nuclear 
DNA-encoded subunit of respiratory chain complex II. Filled blue bars, wild-type foetal livers; filled red bars, 
Shmt2-knockout foetal livers; open blue bars, wild-type foetal brains; open red bars, Shmt2-knockout foetal 
brains. Data represent the mean ± S.D. *P < 0.05; **P < 0.01, Student’s t test (wild-type tissues, n = 4; tissues 
without Shmt2, n = 4). (b) In-gel evaluation of the activity of mitochondrial respiratory chain complex I, 
and detection of mitochondrial respiratory chain complexes I, III, IV, and V by blue native PAGE. To detect 
respiratory chain complexes, gels were stained with Coomassie Brilliant Blue R250 (CBBR).
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and tetrahydrofolate (THF) to glycine and 5,10-methylene-THF (Fig. 4d). Therefore, Shmt2 disruption would 
be expected to induce elevated levels of serine and decreased levels of glycine. As expected, foetal livers without 
functional Shmt2 showed increased amounts of serine and decreased amounts of glycine (Fig. 4e). By contrast, 
the foetal brains without functional Shmt2 showed increased levels of serine but did not show decreased levels of 
glycine (Fig. 4e). These observations could be explained by postulating either a decreased utilization of glycine 
or the presence of additional glycine stores supplying pathways in foetal brains, such as the threonine pathway 
(Fig. 4d), which might rescue foetal brains from manifesting metabolomic defects by the loss of Shmt2 (Fig. 4a).
With respect to taurine metabolism (Figs 4c,d and 5a,b) and nucleotide metabolism (Figs 4c,d and 5c–f) 
affected by Shmt2 disruption in foetal livers, the loss of functional Shmt2 might be responsible for suppressing 
the production of 1C units. Given that the production of active forms of THFs, such as 5,10-methenyl-THF and 
10-formyl-THF, requires 1C units11, their deprivation by Shmt2 disruption in foetal livers would result in depri-
vation of taurine and nucleotide levels (Fig. 5).
Deprivation of taurine in foetal livers without functional Shmt2 (Fig. 5a,b) reduced the levels of subunits 
of mitochondrial respiratory chain complexes (Fig. 1a), because taurine is required for normal translation in 
the mitochondria11. Recent studies proposed that knockout of SHMT2 in human cells induces mitochondrial 
respiration defects as a result of deprivation of taurinomethyl-uridine base15, and that taurine starvation causes 
mitochondrial respiration defects via downregulation of mitochondrial tRNA taurinomethylation28. Therefore, 
reduced levels of taurine exclusively observed in foetal livers without functional Shmt2 (Fig. 5a,b) would subse-
quently decrease levels of the subunits of mitochondrial respiratory chain complexes (Fig. 1) via the insufficient 
taurinomethylation of mitochondrial tRNA, whereas foetal brains without functional Shmt2 did not show these 
abnormalities.
Deprivation of nucleotides in foetal livers lacking functional Shmt2 (Fig. 5c–f) would be responsible for 
growth retardation (Fig. 2), because nucleotides are required for cell division. We observed a decrease in the 
Figure 2. Effects of Shmt2 knockout on the growth of livers and brains from E13.5 embryos. (a) Comparison 
of the weights of tissues or whole embryos between wild-type and Shmt2-knockout mice. WT, wild-type foetal 
livers (filled blue bars), wild-type foetal brains (open blue bars), and wild-type whole embryos (a hatched blue 
bar). KO, Shmt2-knockout foetal livers (filled red bars), Shmt2-knockout foetal brains (open red bars), and 
Shmt2-knockout whole embryos (a hatched red bar). Data represent the means ± S.D. ****P < 0.0001, Student’s 
t test (WT, n = 26; KO, n = 22). (b) Comparison of the total numbers of cells between wildtype and Shmt2-
knockout foetal livers. All cells in each liver from an E13.5 embryo were suspended in 1 mL of PBS containing 
5% FBS by a syringe with a 26-gauge needle. WT, wildtype foetal livers (filled blue bars); KO, Shmt2-knockout 
foetal livers (filled red bars). Data represent the mean ± S.D. ****P < 0.0001, 2-way ANOVA (WT, n = 3; KO, 
n = 4).
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Figure 3. Flow cytometric analysis of liver cells from wild-type and Shmt2-knockout E13.5 embryos. (a) Dead 
cells from wild-type and Shmt2-knockout foetal livers were stained with PI and separated from viable cells using 
flow cytometric analysis. The same number (3 × 104) of viable cells were then analysed using CD71/Ter119 
flow cytometric assay. Representative results (b) and quantitative evaluation (c) of flow cytometric analysis 
of foetal liver cells. In the E13.5 embryonic stage, foetal livers function as erythropoietic sites, with most cells 
in the foetal liver representing progenitors of erythrocytes. In wild-type embryos (embryos without deficient 
Shmt2), most progenitors are at stage II (a CD71High/Ter119High subset mostly consisting of erythroblasts). In 
Shmt2-knockout embryos, >30% of cells are at the undifferentiated stage I (a CD71High/Ter119Middle subset 
mostly consisting of pro-erythroblasts), indicating the arrest of erythroblast differentiation. Cells further along 
in differentiation [i.e., stage III (a CD71Middle/Ter119High subset mostly consisting of reticulocytes) and stage IV 
(a CD71Low/Ter119High subset mostly consisting of matured erythrocytes)], are rare, even in wild-type embryos. 
WT, wild-type foetal livers (solid blue bars); KO, Shmt2-knockout foetal livers (solid red bars). Data represent 
the mean ± S.D. ****P < 0.0001, 2-way ANOVA (WT, n = 3; KO, n = 4).
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quantity of substrates and precursors for purines (Fig. 5c,d) and pyrimidines (Fig. 5e,f) exclusively in foetal livers 
without functional Shmt2. By contrast, foetal brains without functional Shmt2 did not show these abnormalities, 
suggesting that tissue-specific reductions in nucleotide metabolisms might induce significant growth retardation 
of foetal livers lacking functional Shmt2 (Fig. 2) as a consequence of the insufficient production of nucleotides 
(Fig. 5d,f) required for rapid cell division. Therefore, different foetal tissues rely differently on Shmt2, with the 1C 
metabolome of foetal livers being especially sensitive.
Given that mouse embryonic stem cells depend entirely on the threonine pathway for 1C metabolism rather 
than the serine pathway29, it is probable that most mouse embryonic tissues also use the threonine pathway 
(Fig. 4d) to produce taurine and nucleotides required for mitochondrial respiratory function and cell division, 
respectively. We examined whether foetal livers additionally activate the serine pathway (Fig. 4d) by upregulation 
of Shmt2 in response to increasing demands for 1C sources to support rapid cell division and cell differentia-
tion required for erythropoiesis in developing 13.5E foetal livers. As expected, the results showed that the levels 
Figure 4. Metabolomic profiles of livers and brains from wild-type and Shmt2-knockout E13.5 embryos. 
(a) PCA of livers and brains to compare metabolomic data between wild-type and Shmt2-knockout E13.5 
embryos. WT, wild-type foetal livers (closed blue circles), wild-type foetal brains (open blue circles); KO, 
Shmt2-knockout foetal livers (closed red circles), Shmt2-knockout foetal brains (open red circles). (b) 
Volcano plots of metabolomic changes caused by Shmt2 knockout in livers and brains from E13.5 embryos. 
Broken lines, threshold of significance; red dots, serine; blue dots, glycine; orange dots, threonine; black dots, 
metabolites exhibiting significant changes; grey dots, metabolites without significant changes. (c) Pathway 
analysis of metabolomic changes caused by Shmt2 knockout in livers and brains from E13.5 embryos. Broken 
lines, threshold of significance; black dots, pathways with significant changes; red dots, pathways involved 
in 1C metabolism with significant changes, including taurine metabolism, purine metabolism, pyrimidine 
metabolism, and glycine, serine, and threonine metabolism; and grey dots, pathways without significant 
changes. Pathway impact represents a combination of the centrality and pathway enrichment results. (d) A 
scheme of mitochondrial 1C metabolism in the livers of Shmt2-knockout E13.5 embryos. A red character 
denotes a metabolite that increased; a blue character denotes a metabolite that decreased; a black character 
denotes a metabolite that was unchanged in foetal liver without functional Shmt2; grey characters denote 
metabolites not quantified in this study. THF, tetrahydrofolate; 5,10-me-THF, 5,10-methylenetetrahydrofolate; 
τ m5U, 5-taurinomethyluridine; fMet, formylmethionine. (e) Effects of Shmt2 knockout on concentrations of 
serine, glycine, and threonine in livers or brains from E13.5 embryos. WT, wildtype foetal livers (filled blue 
bars) and wild-type foetal brains (open blue bars); KO, Shmt2-knockout foetal livers (filled red bars) and Shmt2-
knockout foetal brains (open red bars). Data represent the mean ± S.D. *P < 0.05; **P < 0.01, ***P < 0.001 
(WT, n = 5; KO, n = 5).
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of Shmt2 involved in the serine pathway were significantly higher in foetal livers than foetal brains (Fig. S3a). 
However, disruption of Shmt2 did not induce compensatory upregulation of Gcat involved in the threonine path-
way or Gldc and Amt involved in the glycine cleavage system (GCS) in both foetal livers and brains (Fig. S3b), sug-
gesting that foetal brains produce sufficient 1C sources without upregulation of these genes, even in the absence of 
Shmt2. Therefore, dependence on the serine pathway in foetal livers is much higher than that in foetal brains and 
represents one of the reasons why foetal livers are significantly influenced by Shmt2 disruption.
Discussion
This study identified potential mechanisms by which Shmt2 disruption induces mitochondrial respiration defects 
and growth retardation and the manner in which these abnormalities are preferentially manifested in the livers of 
Shmt2-knockout E13.5 embryos and induce anaemia.
Figure 5. Effects of Shmt2 knockout on taurine, purine, and pyrimidine metabolism in livers and brains from 
E13.5 embryos. (a) A scheme of taurine metabolism in livers of Shmt2-knockout E13.5 embryos. (b) Effects of 
Shmt2 knockout on the concentrations of metabolites included in taurine metabolism on the livers or brains 
from E13.5 embryos. (c) A scheme of purine metabolism in livers of Shmt2-knockout E13.5 embryos. (d) Effects 
of Shmt2 knockout on the concentrations of metabolites included in purine metabolism on livers or brains from 
E13.5 embryos. (e) A scheme of pyrimidine metabolism in livers of Shmt2-knockout E13.5 embryos. (f) Effects 
of Shmt2 knockout on the concentrations of metabolites included in pyrimidine metabolism on livers or brains 
from E13.5 embryos. Red characters denote metabolites that increased; blue characters denote metabolites 
that decreased; black characters denote metabolites unchanged in foetal liver without functional Shmt2; and 
grey characters denote metabolites not quantified in this study. WT, wild-type foetal livers (solid blue bars) and 
wild-type foetal brains (open blue bars); KO, Shmt2-knockout foetal livers (solid red bars) and Shmt2-knockout 
foetal brains (open red bars). Data represent the mean ± S.D. *P < 0.05; **P < 0.01, ***P < 0.001 (WT, n = 5; 
KO, n = 5).
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The livers but not the brains from Shmt2-knockout E13.5 embryos exhibit mitochondrial respiration defects 
and growth retardation. Because E13.5 foetal liver is an erythropoietic tissue23, growth retardation of foetal liv-
ers without functional Shmt2 directly induces the depletion of erythroblasts and the manifestation of anaemia. 
Furthermore, mitochondrial respiration defects in foetal livers without functional Shmt2 might also induce the 
depletion of erythroblasts by the arrest of erythroblast differentiation. This assertion is supported by our previous 
finding24 that anaemia is induced by the transplantation of adult bone marrow cells exhibiting mitochondrial res-
piration defects caused by the inclusion of mtDNA harbouring a large-scale deletion mutation30,31 into irradiated 
normal mice as a consequence of the differentiation arrest of erythroblasts from transplanted bone marrow cells. 
Elevated mutagenesis of mtDNA and the resulting mitochondrial respiration defects have also been shown to 
arrest erythroblast differentiation and induce anaemia in adult mice25.
Moreover, mitochondrial respiration defects not only impair cell differentiation but also cell division, given 
that growth retardation was induced in mouse tumour cells expressing the respiration defects32,33 by introduc-
tion of mouse mtDNA harbouring pathogenic mutations30,34. Therefore, while growth retardation in foetal livers 
induces the depletion of erythroblasts, mitochondrial respiration defects also induce the depletion of erythro-
blasts via inhibition of erythroblast differentiation and division, resulting in the manifestation of anaemia in 
Shmt2-knockout embryos.
Metabolomic analysis revealed the potential mechanisms by which the disruption of Shmt2 induces mito-
chondrial respiration defects and growth retardation. In Shmt2-knockout embryos, we observed liver-specific 
alterations in metabolic pathways that depend on active THF-driven 1C metabolism and facilitate the synthesis 
of taurine and nucleotides. Specifically, we found decreased levels of taurine, which is required for translation in 
mitochondria and thereby for mitochondrial respiratory function. Moreover, downregulation of de novo nucleo-
tide synthesis induces growth retardation11. Therefore, abnormalities in these 1C cycle-dependent pathways likely 
explain the defects observed in mitochondrial respiratory function and growth.
Metabolomic analysis also revealed the reason why mitochondrial respiration defects and growth retarda-
tion occur preferentially in the livers but not the brains of Shmt2-knockout E13.5 embryos (Figs 4 and S1). The 
serine pathway includes Shmt2 and converts serine and THF to glycine and 5,10-me-THF to produce taurine 
and nucleotides required for mitochondrial respiratory function and cell division, respectively. By contrast, the 
threonine pathway does not include Shmt2 and converts threonine to glycine and produces 5,10-me-THF via the 
GCS, resulting in the production of taurine and nucleotides (Fig. 4d). Our results suggest that foetal brains use the 
threonine pathway to supply glycine (Fig. 4d) and are able to escape from mitochondrial respiration defects and 
growth retardation by the conversion of glycine to 5,10-me-THF via the GCS, thereby eluding the manifestation 
of NTDs. This explanation is supported by findings that the disruption of either Gldc21 or Amt19, both of which are 
involved in the GCS, induces NTDs and embryonic lethality.
Therefore, mouse embryos appear to show lethality via at least two tissue-specific crises and exhibit either 
NTDs or anaemia by the disruption of the genes involved in mitochondrial 1C metabolism and the resulting 
deprivation of their products. The first crisis is the occurrence of NTDs by the disruption of Gldc21 or Amt19, and 
the second crisis is the occurrence of anaemia by the disruption of Shmt214 or Mhtfd218. Embryos without func-
tional Shmt2 can overcome the first crisis by exploiting the threonine pathway and the GCS, which do not involve 
Shmt2, as sources of 1C products in the neural tube.
However, Shmt2-knockout embryos eventually show lethality resulting from the second crisis (i.e., the mani-
festation of anaemia). Increasing demands for the products of 1C metabolism in foetal livers due to erythropoiesis 
activate the serine pathway, which involves Shmt2. Therefore, foetal livers without functional Shmt2 manifest abnor-
malities that include anaemia. In the case of Mthfd2-knockout mouse embryos, their brains do not show NTDs18 
and are capable of growing with the help of Mthfd2L, which corresponds to a paralogous gene of Mthfd2 and thus 
compensates for disrupted Mthfd2. By contrast, because of increasing demands for the products of 1C metabolism 
required for erythropoiesis in foetal livers, Mthfd2L would not be sufficient to compensate for disrupted Mthfd2 due 
to its lower activity relative to that of Mthfd2, resulting in growth retardation and the manifestation of anaemia18.
This study elucidated the potential mechanisms by which the disruption of Shmt2 induces embryonic anaemia 
in Shmt2-knockout mouse embryos. Shmt2 deficiency induced foetal-liver-specific downregulation of 1C sources 
required for mitochondrial respiratory function and cell division, resulting in manifestation of mitochondrial 
respiration defects and growth retardation, respectively. Given that livers function to produce erythroblasts in 
mouse E13.5 developing embryos, these abnormalities could be responsible for deprivation of erythroblasts and 
manifestation of embryonic anaemia. However, to provide direct evidence that Shmt2 deficiency induces deple-
tion of erythroblasts in foetal livers as a consequence of downregulation of 1C sources, further investigation is 
required to show a rescue effect in Shmt2-knockout embryos by supplementation of 1C sources, such as formate 
and glycine, to pregnant mice.
We previously proposed that age-related mitochondrial respiration defects in human fibroblasts from 
elderly subjects8,10 are the results of epigenetic controls, which induce age-associated downregulation of nuclear 
DNA-encoded genes, such as SHMT2 involved in 1C metabolism14. The results in this study also suggest that 
age-associated downregulation of SHMT2 would furthermore control age-related growth retardations, as well 
as mitochondrial respiration defects, in human fibroblasts from elderly subjects. Therefore, activation of SHMT2 
or uptake of certain supplementary 1C sources, such as formate and glycine, might thwart the manifestation of 
age-related disorders. Moreover, administration of these supplements to pregnant mothers might rescue embry-
onic anaemia caused by inactivation of SHMT2. By contrast, activation of SHMT2 or intake of these supplements 
might enhance tumour growth due to the fact that SHMT2 is activated in certain human tumour cells, and that 
its disruption suppresses tumour growth, as well as respiratory function15,16. Therefore, it appears to be contro-
versial whether the activation of SHMT2 or intake of these supplements extends lifespan by restoring mitochon-
drial respiratory function and cell division or shortens lifespan by the activation of tumour growth and tumour 
progression.
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To resolve this controversial issue, further investigation is required to examine the lifespan of and tumour 
formation frequency in heterozygous Shmt2 m/+ mice, which express half the level of SHMT2 protein but do not 
experience embryonic lethality and anaemia14.
Methods
Ethics statement. All animal experiments were performed in accordance with protocols approved by the 
Institutional Animal Care and Use Committee of University of Tsukuba, Japan (Permit Number: 15-313).
Genotyping of mice with and without Shmt2. For genotyping of wild-type and Shmt2-knockout mice, 
DNA samples from the tails of adult mice or embryos were prepared using the Maxwell 16 system (Promega, 
Madison, WI, USA). PCR was performed using a TaKaRa Ex Taq DNA polymerase Hot Start version (Takara Bio, 
Shiga, Japan) and the following primer set: 5′-gag ttg acc aaa act gcc ct-3′, and 5′-tca agc ccc ata aac tgg tc-3′. The 
amplified samples were digested with XcmI to identify a mutation in Shmt214.
Western blot analysis. Proteins separated by SDS-polyacrylamide gel electrophoresis in 8% or 12% 
gels were transferred to polyvinylidene difluoride (PVDF) membranes that were blocked with PVDF block-
ing reagent for Can Get Signal (Toyobo, Osaka, Japan) for 1 h then incubated with primary antibodies against 
SHMT2 (1:1,000; #12762; Cell Signaling Technology, Danvers, MA, USA), NDUFS4 (1:1,000; ab139178; Abcam, 
Cambridge, UK), NDUFA9 (1:1,000; ab14713; Abcam), MT-CO1 (1:1,000; ab14705; Abcam), SDHA (1:1,000; 
#11998S; Cell Signaling Technology), or β-ACTIN (1:5,000; A1978; Sigma-Aldrich, St. Louis, MO, USA) over 
night at 4 °C [Can Get Signal immunoreaction enhancer solution 1 (Toyobo) was used for dilution]. The mem-
branes were then incubated with horseradish peroxidase-conjugated secondary antibodies against rabbit IgG 
(1:10,000; G-21234; Thermo Fisher Scientific, Waltham, MA, USA) or mouse IgG (1:10,000; G-21040; Life 
Technologies/Thermo Fisher Scientific, Carlsbad, CA, USA) for 1 h at room temperature [Can Get Signal immu-
noreaction enhancer solution 2 (Toyobo) was used for dilution]. Bands were detected with a bio-imaging analyser 
(EZ-Capture ST; ATTO, Tokyo, Japan) using ECL Select western blotting detection reagent (GE Healthcare, Little 
Chalfont, UK).
Blue native polyacrylamide gel electrophoreses (PAGE). The crude mitochondrial fraction was 
isolated from homogenates of foetal liver and brain by centrifugation (900 g for 5 min), followed by collec-
tion of the supernatant and re-centrifugation at 5,000 g for 10 min. Isolated mitochondrial fractions were sol-
ubilized with solubilisation buffer [1.5 M aminocaproic acid and 50 mM Bis-Tris (pH 7.0) containing 1.5% 
n-dodecyl-β-D-maltoside] and centrifuged at 40,000 g for 30 min. The resulting supernatants were subjected to 
electrophoresis (8 μg/lane) conducted using NativePAGE 3–12% Bis-Tris protein gels (Thermo Fisher Scientific, 
Waltham, MA). To detect respiratory chain complexes, gels were incubated in staining buffer [2.5 mg/mL 
Coomassie Brilliant Blue R250 (CBBR) in 45% MeOH/10% acetic acid] overnight. The gels were then washed 
with wash buffer (45% MeOH/10% acetic acid) several times until the complex bands became visible. To evaluate 
in-gel complex I activity, gels were incubated in assay buffer [2 mM Tris-HCl, 0.1 mg/mL NADH, and 2.5 mg/mL 
nitro blue tetrazolium chloride (pH 7.4)].
Cell count and flow cytometry. Foetal liver was dispersed using a syringe with a 26-gauge needle to obtain 
foetal liver cells, which were suspended in 1 mL of phosphate-buffered saline (PBS) containing 5% foetal bovine 
serum (FBS). A part of the suspension (20 μL) was used for the cell count, and the remaining was passed through 
a nylon mesh (70 μm) for immunostaining with PE-conjugated anti-Ter119 (Miltenyi Biotec, Bergisch Gladbach, 
Germany) and APC-conjugated anti-CD71 (Thermo Fisher Scientific) antibodies for 30 min at 4 °C. After wash-
ing the cells with PBS containing 5% FBS, dead cells were stained with PI (2 μg/mL) for 10 min at 4 °C. Flow cyto-
metric analysis using ~3 × 104 viable cells from a foetal liver was performed using a FACSCalibur flow cytometer 
(BD Biosciences, Franklin Lakes, NJ, USA) with CellQuest software (BD Biosciences). Data were analysed with 
FlowJo 7.6 software (Tree Star, Ashland, OR, USA).
Quantitative mass spectrometry based targeted metabolomics. Metabolites were extracted 
from ~15 mg of frozen tissues and separated using an Acquity ultra-pressure liquid chromatography system and 
analysed using a Xevo TQ-S triple quadrupole mass spectrometer (Waters Corporation, Milford, MA, USA). 
Complete descriptions of the methods, including instrument parameters and validation, are provided else-
where35. The resulting targeted metabolomics data were analysed using MetaboAnalyst 3.0 (www.metabolan-
alyst.ca)36,37, log-transformed, and auto-scaled prior to statistical analysis. Separation among groups was tested 
by unsupervised multivariate analysis and PCA. To identify which metabolic pathways were significant with 
“hub” nodes, we performed metabolic pathway topological analysis. Quantitative data was mapped, and a mouse 
metabolite-pathway library with 82 entries was selected. The other parameters chosen were for global testing and 
betweenness-centrality node measurement. Pathway analysis results were displayed as a metabolome view graph.
Quantification of mRNA levels by real-time quantitative PCR. Total RNA was extracted from the 
livers and brains of wild-type or shmt2-knockout mice using the RNeasy mini kit (Qiagen). RNA samples were 
reverse-transcribed using a high-capacity cDNA reverse transcription kit (Thermo Fisher Scientific). Real-time 
PCR was performed with GeneAce SYBR qPCR mix α (Nippon Gene, Tokyo, Japan), on an ABI PRISM 7900HT 
sequence detection system (Applied Biosystems, Foster City, CA, USA) and using primers for Shmt2 (forward, 
ctgcagagggagaaggacag; reverse, ctcggctgcagaagttctct), Gcat (forward, gcctatttgaggctttgctg; reverse, gtggcggtaacg-
gtacttgt), Gldc (forward, actgtggatcttcggctgtg; reverse, gaacgggctggttctcttga), Amt (forward, tactacacctgtggagggca; 
reverse, cacatatcagccccacacgt) and Tbp (forward, ctggaattgtaccgcagctt; reverse, atgatgactgcagcaaatcg). The relative 
expression levels of each mRNA were calculated using the ΔΔCt method, with Tbp used as an internal control.
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Statistical analysis. Data were analysed by two-sided Student’s t test or analysis of variance (ANOVA) or 
Tukey-Kramer method. A P < 0.05 was considered significant.
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